유럽의 정위적 기기 시장

※ 본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

유럽 국가의 정위적 기기(Stereotactic Devices) 시장에 대해 분석했으며, 전체적인 시장 규모 동향 전망(판매량·매출·평균 가격, 시장 성장률 등), 제품 카테고리별 동향, 주요 시장 성장 촉진·억제요인, 최근 자본 거래 동향과 시장 상황, 기업별 시장 점유율, 시장의 전체적 동향(질환·제품 개요, 시술 건수, 임상시험 동향 등), 각국 시장 배경 등의 정보를 전해드립니다.

주요 요약

유럽의 신경조절, 신경혈관, 신경외과, 모니터링 기기 시장 개요

경쟁 분석

시장 동향

시장 발전

분석 대상 시장

분석 대상 시술

주요 분석 업데이트

과거 버전

제1장 분석 방법

• 분석 범위
• IDATA의 9 단계 분석 방법

제2장 질환 개요

• 인체의 기본 구조
• 병태생리와 질환
  • 서론
  • 일반적인 진단법과 신경외과
  • 종양 및 뇌종양
  • 뇌동정맥기형
  • 허혈성 뇌졸중
  • 뇌정맥류
  • 뇌척수액 및 두개내압 관련 장애
    • 뇌수종 및 두개내압장애
    • 뇌부종
  • 신경변조의 적응증
  • 외상성 뇌손상

제3장 각국 개요

• 서론
  • 총인구
  • 1인당 GDP
  • 가격 지수
• 독일
• 프랑스
• 영국
• 이탈리아
• 스페인
• 베네룩스 국가
• 북유럽 국가
• 오스트리아
• 스위스
• 포르투갈

제4장 제품 평가

• 제품 포트폴리오
  • 정위적 기기
    • 서론
    • 제품 매트릭스 : 핵심 기업
• 규제상 문제와 리콜
• 임상시험 상황

제5장 정위적 기기 시장

• 서론
• 시장 개요
• 시장 분석과 예측
  • 프레임 기반 정위적 기기 시장
  • 비프레임 정위적 기기 시장
• 설치 대수 분석
  • 프레임 기반 정위적 기기 시장
  • 비프레임 정위적 기기 시장
• 시장 성장 촉진·억제요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
• 기업별 시장 점유율 분석

약어

부록 : 각 기업의 프레스 릴리스

도표

Stereotaxy allows neurosurgeons to localize targets within patient's brains using methodology that incorporates coordinate systems with diagnostic image information. It was first conducted in 1908 by two British scientists, Sir Victor Horsley and Robert H. Clarke who placed frames on small animals based on external anatomical landmarks to navigate to specific points in their brains. This technology was not yet precise enough to be used in human subjects.

General Report Contents:

• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions

Stereotaxy has become the standard of care in neurosurgery and is now used in the majority of cranial cases. This has led to market saturation; however, there will still be some growth in unit sales as facilities that did not want to share multi-application platforms between hospital departments purchase additional units.

The market has been increasingly transitioning to the use of frameless stereotactic systems which can be used for pre-surgical planning as well as guidance through most cranial procedures. These devices incorporate superior technology and updated features.

However, frame-based systems remain the golden standard in terms of accuracy and are more commonly used for small targets and procedures like the implantation of deep brain stimulators. This benefit will allow them to maintain their share of the market until frameless technology reaches the same level of accuracy.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

MARKETS INCLUDED

PROCEDURES INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

• 1.1. RESEARCH SCOPE
• 1.2. IDATA'S 9-STEP METHODOLOGY
  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

• 2.1. BASIC ANATOMY
• 2.2. DISEASE PATHOLOGY AND DISORDERS
  • 2.2.1. Introduction
  • 2.2.2. General Diagnostics and Neurosurgery
  • 2.2.3. Tumor and Brain Cancer
  • 2.2.4. Brain Arteriovenous Malformations
  • 2.2.5. Ischemic Stroke
  • 2.2.6. Brain Aneurysm
  • 2.2.7. Disorders Related to Cerebrospinal Fluids and Intracranial Pressure
    • 2.2.7.1. Hydrocephalus and Intracranial Pressure Disorder
    • 2.2.7.2. Cerebral Edema
  • 2.2.8. Indication for Neuromodulation
  • 2.2.9. Traumatic brain injury

COUNTRY PROFILES

• 3.1. INTRODUCTION
  • 3.1.1. Population
  • 3.1.2. GDP Per Capita
  • 3.1.3. Price Index
• 3.2. GERMANY
• 3.3. FRANCE
• 3.4. UNITED KINGDOM
• 3.5. ITALY
• 3.6. SPAIN
• 3.7. BENELUX
• 3.8. SCANDINAVIA
• 3.9. AUSTRIA
• 3.10. SWITZERLAND
• 3.11. PORTUGAL

PRODUCT ASSESSMENT

• 4.1. PRODUCT PORTFOLIOS
  • 4.1.1. Stereotactic Devices
    • 4.1.1.1. Introduction
    • 4.1.1.2. Product Matrix for Stereotactic Devices: Core Companies
• 4.2. REGULATORY ISSUES AND RECALLS
  • 4.2.1. Stereotactic Devices
• 4.3. CLINICAL TRIALS
  • 4.3.1. Stereotactic Devices

STEREOTACTIC MARKET

• 5.1. INTRODUCTION
• 5.2. MARKET OVERVIEW
• 5.3. MARKET ANALYSIS AND FORECAST
  • 5.3.1. Frame-Based Stereotactic Market
  • 5.3.2. Frameless Stereotactic Market
• 5.4. INSTALLED BASE ANALYSIS
  • 5.4.1. Frame-Based Stereotactic Market
  • 5.4.2. Frameless Stereotactic Market
• 5.5. DRIVERS AND LIMITERS
  • 5.5.1. Market Drivers
  • 5.5.2. Market Limiters
• 5.6. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

LIST OF CHARTS

• Chart 1-1: Neurological Device Market by Segment, Europe, 2013 - 2023
• Chart 1-2: Neurological Device Market Overview, Europe, 2013 &2023
• Chart 3-1: Country Profile, Germany, 2016
• Chart 3-2: Country Profile, France, 2016
• Chart 3-3: Country Profile, United Kingdom, 2016
• Chart 3-4: Country Profile, Italy, 2016
• Chart 3-5: Country Profile, Spain, 2016
• Chart 3-6: Country Profile, Benelux, 2016
• Chart 3-7: Country Profile, Scandinavia, 2016
• Chart 3-8: Country Profile, Austria, 2016
• Chart 3-9: Country Profile, Switzerland, 2016
• Chart 3-10: Country Profile, Portugal, 2016
• Chart 5-1: Stereotactic Market by Segment, Europe, 2013 - 2023
• Chart 5-2: Stereotactic Market Breakdown, Europe, 2016
• Chart 5-3: Stereotactic Market Breakdown, Europe, 2023
• Chart 5-4: Frame-Based Stereotactic Market, Europe, 2013 - 2023
• Chart 5-5: Frameless Stereotactic Market, Europe, 2013 - 2023
• Chart 5-6: Leading Competitors, Stereotactic Market, Europe, 2016

LIST OF FIGURES

• Figure 1-1: Neurological Device Market Share Ranking by Segment, Europe, 2016 (1 of 3)
• Figure 1-2: Neurological Device Market Share Ranking by Segment, Europe, 2016 (2 of 3)
• Figure 1-3: Neurological Device Market Share Ranking by Segment, Europe, 2016 (3 of 3)
• Figure 1-4: Companies Researched in this Report, Europe, 2016
• Figure 1-5: Factors Impacting the Neurological Device Market by Segment, Europe (1 of 3)
• Figure 1-6: Factors Impacting the Neurological Device Market by Segment, Europe (2 of 3)
• Figure 1-7: Factors Impacting the Neurological Device Market by Segment, Europe (3 of 3)
• Figure 1-8: Recent Events in the Neurological Device Market, Europe, 2014 - 2016
• Figure 1-9: Neurological Device Markets Covered, Europe, 2016
• Figure 1-10: Neurological Device Procedures Covered, Europe, 2016
• Figure 1-11: Key Report Updates
• Figure 1-12: Version History
• Figure 2-1: Neurology Disease Overview
• Figure 2-2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016
• Figure 4-1: Class 2 Device Recall: StealthStation System, Medtronic Navigation, Inc.
• Figure 4-2: Class 2 Device Recall: Leksell Gamma Knife Perfexion and Leksell Gamma Knife Icon, Elekta, Inc
• Figure 4-3: Class 2 Device Recall: Brainlab Cranial Navigation System, Brainlab AG
• Figure 4-4: Class 2 Device Recall: Brainlab AG
• Figure 4-5: Class 2 Device Recall: Brainlab
• Figure 4-6: Class 2 Device Recall: Stereotactic Circular Collimator 3D Line stereotactic Hardware Accessories
• Figure 4-7: Class 2 Device Recall: 43410 FRAMELESS SRS QA TARGET POINTER
• Figure 4-8: Class 2 Device Recall: Integra Xknife Stereotactic Radiosurgery and Radiotherapy Treatment Planning
• Figure 4-9: Class 2 Device Recall: CRW Precision Arc (CRWPRECISE), CRW Arc System (CRWASL)
• Figure 4-10: Stereotactic Device: Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors
• Figure 4-11: Stereotactic Device: Protocol for Staged Stereotactic Radiosurgery for Large Arteriovenous Malformations
• Figure 5-1: Stereotactic Market by Segment, Europe, 2013 - 2023 (€M)
• Figure 5-2: Stereotactic Market by Segment, Europe, 2013 - 2023 (US$M)
• Figure 5-3: Frame-Based Stereotactic Market, Europe, 2013 - 2023 (€ and US$)
• Figure 5-4: Units Sold by Country, Frame-Based Stereotactic Market, Europe, 2013 - 2023
• Figure 5-5: Average Selling Price by Country, Frame-Based Stereotactic Market, Europe, 2013 - 2023 (€)
• Figure 5-6: Average Selling Price by Country, Frame-Based Stereotactic Market, Europe, 2013 - 2023 (US$)
• Figure 5-7: Market Value by Country, Frame-Based Stereotactic Market, Europe, 2013 - 2023 (€M)
• Figure 5-8: Market Value by Country, Frame-Based Stereotactic Market, Europe, 2013 - 2023 (US$M)
• Figure 5-9: Frameless Stereotactic Market, Europe, 2013 - 2023 (€ and US$)
• Figure 5-10: Units Sold by Country, Frameless Stereotactic Market, Europe, 2013 - 2023
• Figure 5-11: Average Selling Price by Country, Frameless Stereotactic Market, Europe, 2013 - 2023 (€)
• Figure 5-12: Average Selling Price by Country, Frameless Stereotactic Market, Europe, 2013 - 2023 (US$)
• Figure 5-13: Market Value by Country, Frameless Stereotactic Market, Europe, 2013 - 2023 (€M)
• Figure 5-14: Market Value by Country, Frameless Stereotactic Market, Europe, 2013 - 2023 (US$M)
• Figure 5-15: Installed Base, Frame-Based Stereotactic Market, Europe, 2013 - 2023
• Figure 5-16: Installed Base, Frameless Stereotactic Market, Europe, 2013 - 2023
• Figure 5-17: Drivers and Limiters, Stereotactic Market, Europe, 2016
• Figure 5-18: Leading Competitors, Stereotactic Market, Europe, 2016
• Figure 5-19: Leading Competitors by Country, Frame-Based Stereotactic Market, Europe, 2016
• Figure 5-20: Leading Competitors by Country, Frameless Stereotactic Market, Europe, 2016
• Figure 7-1: Press Release Summary